Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritis

The Lancet Regional Health - Americas · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles